Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Avanzanite Bioscience B.V.

Avanzanite Expands Italian Operations with General Manager Appointment
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Bioscience Welcomes Dr. Mark Bechter as SVP Medical Affairs
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Bioscience Appoints Sotiris Botozis as General Manager Southern Europe
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Bioscience Appoints Chief Financial Officer
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Bioscience Announces Appointment of Chief Technical Officer to Accelerate European Expansion and Drive Growth
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Bioscience Reports European Commission's Authorisation of Orphan Medicinal Product AKANTIOR®
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Bioscience Reports AKANTIOR® Received Positive CHMP Opinion and Announces Corporate Expansion Into 26 European Countries
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Bioscience Further Strengthens Leadership Team With Country Manager of Germany
From Avanzanite Bioscience B.V.
Via Business Wire
Avanzanite Bioscience Partners With Advicenne to Commercialize Sibnayal® For the Treatment of Rare Kidney Disease in Germany, Austria, Switzerland and Greece
From Avanzanite Bioscience B.V.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.